Because both BRMS1 and CXCR4 are involved in regulating the NF-κB signaling pathway, we hypothesized that BRMS1 might modulate metastasis of ovarian cancer cells in part by regulating CXCR4 expression. This evidence concerns the gene NFKB1 and ovarian carcinoma.